Digital Content 
NEWS #PharmaBuzz
01 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/biocodex-to-present-new-data-at-the-american-epilepsy-society-aes-2025-annual-meeting-302620684.html
14 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/new-development-in-rare-pediatric-epilepsy-biocodex-announces-the-development-of-diacomit-stiripentol-oral-suspension-a-new-formulation-to-aid-in-the-treatment-of-dravet-syndrome-in-young-children-302306052.html
21 Sep 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/antiseizure-drug-diacomit-now-approved-for-children-as-young-as-6-months-301628988.html
27 Jun 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/pantherx-rare-announces-partnership-with-biocodex-for-the-distribution-of-diacomit-stiripentol-for-the-treatment-of-seizures-associated-with-dravet-syndrome-in-patients-2-years-of-age-and-older-taking-clobazam-301575862.html
14 Sep 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/m8-pharmaceuticals-announces-license-of-exclusive-rights-for-diacomit-stiripentol-from-biocodex-sas-301376198.html
27 Jun 2019
// Mark Terry BIOSPACE
https://www.biospace.com/article/zogenix-given-go-ahead-to-resubmit-fintepla-to-fda-for-dravet-syndrome/
Share 